Lightstone Ventures
Christina K. Isacson Ph.D. has a wealth of experience in the biotechnology and pharmaceutical industry, holding various leadership positions at companies such as Tagworks Pharmaceuticals, Blavatnik Biomedical Accelerator, and Lightstone Ventures. Christina K. has a background in neuroscience and biology/business from Tufts University School of Medicine and McGill University, respectively.
This person is not in the org chart
Lightstone Ventures
Lightstone Ventures is a global venture capital fund dedicated to translating novel scientific breakthroughs into clinically and commercially meaningful therapies. We invest in biotech and medtech companies pioneering the big ideas poised to transform patient outcomes. We were founded in 2012 to empower visionary entrepreneurs with the resources and operational guidance necessary bring innovative therapeutics and technologies to the people who need them most. Our investment team has led deals resulting in 19 acquisitions and 20 initial public offerings over the last two decades. We have offices in Boston, Mass., Menlo Park, Calif., and Dublin, Ireland. For more information, visit www.lightstonevc.com.